X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-29-2023-18805.pdf
https://www.globenewswire.com//news-release/2023/10/10/2757986/7767/en/MediciNova-Receives-a-Notice-of-Allowance-for-a-New-Patent-Covering-the-Combination-of-MN-166-ibudilast-and-Riluzole-for-the-Treatment-of-Amyotrophic-Lateral-Sclerosis-ALS-in-Canad.html
https://www.globenewswire.com/news-release/2022/03/03/2396245/0/en/Aquestive-Therapeutics-and-Haisco-Pharmaceutical-Group-Enter-Licensing-and-Supply-Agreement-for-Riluzole-Oral-Film-for-ALS-Treatment-in-China.html
https://www.nih.gov/news-events/news-releases/repurposed-als-drug-shows-promise-mouse-model-rare-childhood-genetic-disorder
https://www.mt-pharma-america.com/2021/06/30/mitsubishi-tanabe-pharma-america-announces-exservan-riluzole-is-now-available-in-the-u-s-for-the-treatment-of-als/
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-announces-exservan-riluzole-is-now-available-in-the-us-for-the-treatment-of-als-301323162.html
https://www.prnewswire.com/news-releases/mitsubishi-tanabe-pharma-america-and-aquestive-therapeutics-announce-us-licensing-and-supply-deal-for-riluzole-oral-film-for-als-treatment-301212571.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206045
https://www.biospace.com/article/aquestive-therapeutics-nabs-approval-for-sublingual-formulation-of-als-drug/?s=62
https://www.globenewswire.com/news-release/2019/11/13/1946353/0/en/Aquestive-Therapeutics-Licenses-Riluzole-Oral-Film-to-Zambon-for-Development-and-Commercialization-in-the-EU-for-Patients-with-ALS.html
https://www.fiercepharma.com/manufacturing/biohaven-suckerpunched-by-crl-tied-to-apotex-warning-letter
https://www.in-pharmatechnologist.com/Article/2019/04/23/FDA-approves-oral-film-for-treatment-of-ALS
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204430
http://www.pmlive.com/pharma_news/daily_brief_summits_$12m_lifeline,_biohavens_speech_anxiety_pill,_crescendos_humabody_progress_1249190
https://www.fiercebiotech.com/orion-take-repurposed-heart-failure-drug-into-phase-3-for-als
https://www.pharmacompass.com/pdf/news/apotex-research-private-limited-on-fda-import-alert-list-1523595152.pdf
https://www.prnewswire.com/news-releases/aquestive-therapeutics-receives-us-fda-orphan-drug-designation-for-riluzole-oral-soluble-film-to-treat-als-300590722.html
https://scicasts.com/channels/bio-it/1858-drug-development/12625-ai-based-personalized-drug-discovery-platform-launched/
https://globenewswire.com/news-release/2017/01/24/910367/0/en/MonoSol-Rx-Appoints-John-T-Maxwell-as-Chief-Financial-Officer.html
http://www.fiercebiotech.com/story/ab-science-jumps-40-optimism-trumps-skepticism-wake-phiii-als-data/2016-04-07
https://www.pharmacompass.com/pdf/news/start-of-a-review-concerning-the-conduct-of-studies-at-the-alkem-laboratories-ltd-site-taloja-india-1460003849.pdf
https://www.pharmacompass.com/pdf/news/alkems-generic-riluzole-approved-in-us-to-treat-amyotrophic-lateral-sclerosis-1459595858.pdf
http://www.pharmatimes.com/Article/15-12-22/New_nectar-like_oral_formulation_for_vital_ALS_drug.aspx
Market Place
Share 
